Therapy of Preconditioned Autologous BMMSCs for Patients With Ischemic Heart Disease

Inclusion Criteria: * Age under 75; * Clinical diagnosis of acute Myocardial Infarction, chronic Myocardial Infarction and Ischemic Cardiomyopathy * NYHA (New York Heart Association) grade: III-IV, LVEF (left ventricular ejection fraction): 25-50%; * No infection diseases including HBV (hepatitis B virus), HCV (hepatitis C virus ), syphilis and AIDS; * No psychiatric illnesses and speaking dysfunction; * Informed consent. Exclusion Criteria: * More than 75 years old; * LVEF\<24%; * Unstable hemodynamics, shock; * Severe infection; * Patients have tumor or other lethal diseases (expectation of life\<6 months); * Radiation patients; * hematopoietic malignancy including Haemophiliacs; * Anemia (Hb\<100g/L); * The other clinical trial participants within one month; * Abnormal increasing of the blood biochemical indicators that is not explained by the conditions; * Informed refusal.